Bloomberg
@business
The first word in business news | Watch Live: | Newsletters: | Podcasts:
参加 April 2009
107 フォロー中 10.5M ファン
CSL agreed to pay as much as $1.6 billion to jointly develop and sell an experimental treatment for rare kidney and liver diseases, expanding the Australian biotech company’s push into kidney medicine
もっと見る
